Cytokine inhibitor monotherapies can ameliorate depression (Kappelmann et al., 2018; Köhler et al., 2019) and antidepressant treatment also significantly decreases peripheral levels of IL‐6, TNF, and IL‐10 (Köhler et al., 2018). This evidence concerns the gene TNF and depressive symptom measurement.